Health AI Central
Share:
Peer-Reviewed Publication
Front Cardiovasc Med2021;8636718.January 1, 2021Case Reports

Clinical Utility of Fluid Volume Assessment in Heart Failure Patients Using Bioimpedance Spectroscopy.

Andrew J Accardi1, Bradley S Matsubara2, Richelle L Gaw3, Anne Daleiden-Burns4, James Thomas Heywood4
1Department of Emergency Medicine, Scripps Memorial Hospital Encinitas, Encinitas, CA, United States.
2ImpediMed, Inc., Carlsbad, CA, United States.
3ImpediMed Limited, Brisbane, QLD, Australia.
4Heart Failure Recovery and Research Program, Scripps Memorial Hospital La Jolla, La Jolla, CA, United States.
PubMed PMC DOI PDF

Abstract

Background: Bioimpedance spectroscopy (BIS) is a non-invasive method used to measure fluid volumes. In this report, we compare BIS measurements from patients with heart failure (HF) to those from healthy adults, and describe how these point-of-care fluid volume assessments may be applied to HF management. Methods and results: Fluid volumes were measured in 64 patients with NYHA class II or III HF…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.